Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Vikas Jain, Hitesh Kumar, Haritha V. Anod, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 628-647
Closed Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 86
Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations
Vijayabhaskarreddy Junnuthula, Praveen Kolimi, Dinesh Nyavanandi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1860-1860
Open Access | Times Cited: 75
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
Nanomaterials-assisted photothermal therapy for breast cancer: State-of-the-art advances and future perspectives
Sagnik Nag, Oishi Mitra, G. Tripathi, et al.
Photodiagnosis and Photodynamic Therapy (2024) Vol. 45, pp. 103959-103959
Open Access | Times Cited: 56
Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy
Sergio Liga, Cristina Paul, Elena-Alina Moacă, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 223-223
Open Access | Times Cited: 32
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 19
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer
Liang Shang, Xinglu Zhou, Jiarui Zhang, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6532-6532
Open Access | Times Cited: 70
Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
Rahul Chadar, Afsana, Prashant Kesharwani
International Journal of Pharmaceutics (2021) Vol. 605, pp. 120835-120835
Closed Access | Times Cited: 69
Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
Saikat Ghosh, Ankit Javia, Saritha Shetty, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 27-58
Closed Access | Times Cited: 66
Emerging nanomedicines of paclitaxel for cancer treatment
Qin Chen, Shu Xu, Shuo Liu, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 280-294
Closed Access | Times Cited: 65
Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis
Xiaoyan Gu, Yunzhen Gao, Ping Wang, et al.
Journal of Controlled Release (2021) Vol. 333, pp. 374-390
Closed Access | Times Cited: 64
Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review
Maryam Ghanbari-Movahed, Tea Kaceli, Arijit Mondal, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 480-480
Open Access | Times Cited: 63
Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy
Shivaprasad Gadag, Reema Narayan, Archana S. Nayak, et al.
International Journal of Pharmaceutics (2021) Vol. 606, pp. 120877-120877
Open Access | Times Cited: 63
Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer
Kübra Kaban, Clemens Hinterleitner, Yanjun Zhou, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 61
Recent advances in liposome formulations for breast cancer therapeutics
Biyao Yang, Bo-ping Song, Shaina Shankar, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 13, pp. 5225-5243
Closed Access | Times Cited: 59
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic
Ana Isabel Fraguas‐Sánchez, Irene Lozza, Ana Isabel Torres‐Suárez
Cancers (2022) Vol. 14, Iss. 5, pp. 1198-1198
Open Access | Times Cited: 54
Targeted delivery of albumin nanoparticles for breast cancer: A review
Shalvi Sinai Kunde, Sarika Wairkar
Colloids and Surfaces B Biointerfaces (2022) Vol. 213, pp. 112422-112422
Closed Access | Times Cited: 52
Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 1024-1047
Closed Access | Times Cited: 52
Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy
Peiying He, Qi Lei, Bin Yang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13919-13932
Closed Access | Times Cited: 51
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 30
Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy
Hongyan Zhang, Liying Chen, Yue Zhao, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 2, pp. 100796-100796
Open Access | Times Cited: 28
Folic Acid Functionalized Diallyl Trisulfide–Solid Lipid Nanoparticles for Targeting Triple Negative Breast Cancer
Anindita De, Parikshit Roychowdhury, Nihar Ranjan Bhuyan, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1393-1393
Open Access | Times Cited: 23
Nanoscale strides: exploring innovative therapies for breast cancer treatment
Sruthi Laakshmi Mugundhan, M. Mothilal
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14017-14040
Open Access | Times Cited: 13
Nanoparticle‐Based Drug Delivery Platform for Simultaneous Administration of Phytochemicals and Chemotherapeutics: Emerging Trends in Cancer Management
S.M. Kawish, Shwetakshi Sharma, Priya Gupta, et al.
Particle & Particle Systems Characterization (2024)
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top